Informational Bulletin 22-17: Allergy Testing and Allergen Immunotherapy Policy Update
Date: 06/22/22
Louisiana Healthcare Connections would like to inform providers of an update to Informational Bulletin 22-17: Allergy Testing and Allergen Immunotherapy Policy Update published on June 21, 2022.
Allergy Testing and Allergen Immunotherapy
Louisiana Healthcare Connections will cover allergy testing and allergen immunotherapy relating to hypersensitivity disorders manifested by generalized systemic reactions as well as by localized reactions in any organ system of the body. Covered allergy services shall include:
- In vitro specific IgE tests; v Intracutaneous (intradermal) skin tests;
- Percutaneous skin tests; v Ingestion challenge testing; and
- Allergen immunotherapy.
Allergy Testing
Louisiana Healthcare Connections will cover allergy testing for enrollees who have symptoms of allergic disease, such as respiratory symptoms, skin symptoms, or other symptoms that consistently follow a particular exposure, not including local reactions after an insect sting or bite.
Allergen Immunotherapy
Louisiana Healthcare Connections will cover allergen immunotherapy at:
- A minimum of 180 doses every calendar year, per enrollee, for supervision of preparation and provision of antigens other than stinging or biting insects; and
- A minimum of 52 doses every calendar year, per enrollee, for supervision of preparation and provision of antigens related to stinging or biting insects;
Louisiana Healthcare Connections will cover allergen immunotherapy doses exceeding the above quantities when medically necessary.